journal of thrombosis and thrombolysis سال:2018 - دوره:46

Fa | Ar | En


journal of thrombosis and thrombolysis
سال:2018 - دوره:46 - شماره:3

abnormal fibrinogen with an aα 16arg → cys substitution is associated with multiple cerebral infarctions - صفحه:409-419 comment on “do hospital doctors test for thrombophilia in patients with venous thromboembolism?” - صفحه:403-403 effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism - صفحه:339-345 effects of cupric chloride on coagulation in human plasma: role of fibrinogen - صفحه:359-364 elevated extracellular trap formation and contact system activation in acute leukemia - صفحه:379-385 first evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation - صفحه:393-398 highlights from the 2018 american college of cardiology scientific session in orlando, florida - صفحه:431-433 how to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis - صفحه:399-402 impact of cost on use of non-vitamin k antagonists in atrial fibrillation patients in ontario, canada - صفحه:310-315 impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohort - صفحه:325-331 incidence and outcomes of catheter related thrombosis (crt) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen - صفحه:386-392 introduction of direct oral anticoagulant within 7 days of stroke onset: a nomogram to predict the probability of 3-month modified rankin scale score > 2 - صفحه:292-298 micrornas regulate nitric oxide release from endothelial cells by targeting nos3 - صفحه:275-282 non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events - صفحه:283-291 non-vitamin k antagonist oral anticoagulants for the treatment of intracardiac thrombosis - صفحه:332-338 number of ischemic strokes potentially eligible for revascularization treatments in an italian comprehensive stroke center: a modeling study - صفحه:427-430 predictors of coronary stent thrombosis: a case–control study - صفحه:420-426 residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer - صفحه:404-408 the course of acquired von willebrand syndrome during pregnancy among patients with essential thrombocytosis - صفحه:304-309 the effect of cessation of 2nd generation p2y12 inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction - صفحه:351-358 the efficacy and safety of batroxobin in combination with anticoagulation on cerebral venous sinus thrombosis - صفحه:371-378 the ratio of concentrations of aminocaproic acid and tranexamic acid that prevent plasmin activation of platelets does not provide equivalent inhibition of plasmatic fibrinolysis - صفحه:365-370 ticagrelor versus clopidogrel after fibrinolytic therapy in patients with st-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials - صفحه:299-303 total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention - صفحه:346-350 warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “real-world” michigan anticoagulation quality improvement initiative (maqi2) registry to the re-ly, rocket-af, and aristotle trials - صفحه:316-324